Valsartan: Uses, Forms and Safety Reference

Valsartan tablets have US uses in hypertension and selected adult heart conditions. The reason for treatment affects the regimen, while the fetal-toxicity warning and monitoring for kidney and potassium changes apply across those uses.

The approved uses and formulations described here follow US prescribing information. They may differ in other countries.

Medicine detail Details
Active ingredient(s) valsartan
Medicine class Angiotensin II receptor blocker (ARB)
Forms and strengths Single-ingredient oral tablets: 40, 80, 160 and 320 mg; other formulations and fixed combinations excluded

The reason for prescribing matters

The cited label covers hypertension in adults and children aged 1 year and older, reduced heart-failure hospitalization in adults with NYHA class II to IV heart failure, and reduced cardiovascular mortality in selected clinically stable adults after myocardial infarction with left ventricular failure or dysfunction. Each use has its own clinical qualifications.

Source: [1]

Tablets are separate from combination products

This reference covers 40, 80, 160 and 320 mg single-ingredient tablets. Products combining valsartan with sacubitril, hydrochlorothiazide or other medicines have separate instructions. Age, formulation and indication affect administration; do not transfer a tablet regimen to a liquid or combination product without prescribing advice.

Source: [1]

Pregnancy requires immediate contact

Valsartan carries a boxed warning for fetal toxicity. Drugs acting on the renin-angiotensin system can harm or kill a developing fetus; the label directs discontinuation as soon as pregnancy is detected. Anyone planning pregnancy or discovering a pregnancy needs prompt discussion of an alternative with the prescribing team.

Source: [1]

Follow kidney function and potassium

Symptomatic low blood pressure, impaired kidney function and high potassium are important risks. Dehydration, diuretics and other medicines can change those risks. The clinician may arrange blood tests and pressure checks. Coadministration with aliskiren is contraindicated in diabetes; combining renin-angiotensin medicines requires careful review.

Source: [1]

A complete list includes nonprescription medicines

NSAIDs, lithium and potassium-raising products can interact with valsartan. Include salt substitutes and supplements when discussing treatment. Heart-failure and post-infarction schedules should follow the prescription rather than assumptions based on a hypertension regimen. Comparative reading supports understanding, not independent switching or dose conversion.

The Losartan and valsartan comparison provides a separate side-by-side reference, without establishing an individual treatment choice.

Source: [1]

Questions and answers

Does the valsartan strength reveal why it was prescribed?

No. Hypertension, heart failure and post-infarction treatment have different clinical contexts and regimens.

Is sacubitril/valsartan included in this tablet reference?

No. That is a fixed-combination medicine with separate prescribing information.

Why might blood tests be needed with valsartan?

Kidney function and potassium can change during treatment, particularly in susceptible patients or with interacting medicines.

Related reading

Sources

  1. Valsartan: official US prescribing information

Sources checked 27 October 2026. This information does not replace advice from your healthcare professional. For complete warnings and instructions, read the product information and consult the prescribing team.

Reviewed by: Mattias Hagman, PhD

About the reviewer:
Dr Mattias Hagman (PhD, University of Sydney) has an academic background and experience working with healthcare-related content and regulated industries. He has lecturing experience at international universities, including Stockholm University and the University of Malta.

Last reviewed: October 2026